Literature DB >> 29566971

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Xavier Muñoz1, María José Álvarez-Puebla2, Ebymar Arismendi3, Lourdes Arochena4, María Del Pilar Ausín5, Pilar Barranco6, Irina Bobolea3, Jose Antonio Cañas4, Blanca Cardaba4, Astrid Crespo7, Victora Del Pozo4, Javier Domínguez-Ortega6, María Del Mar Fernandez-Nieto4, Jordi Giner7, Francisco Javier González-Barcala8, Juan Alberto Luna6, Joaquim Mullol3, Iñigo Ojanguren9, José María Olaguibel2, César Picado3, Vicente Plaza7, Santiago Quirce6, David Ramos7, Manuel Rial4, Christian Romero-Mesones9, Francisco Javier Salgado8, María Esther San-José8, Silvia Sánchez-Diez9, Beatriz Sastre4, Joaquin Sastre4, Lorena Soto7, Montserrat Torrejón7, Marisa Urnadoz2, Luis Valdes8, Antonio Valero3, María Jesús Cruz9.   

Abstract

The general aim of this study is to create a cohort of asthma patients with varying grades of severity in order to gain greater insight into the mechanisms underlying the genesis and course of this disease. The specific objectives focus on various studies, including imaging, lung function, inflammation, and bronchial hyperresponsiveness, to determine the relevant events that characterize the asthma population, the long-term parameters that can determine changes in the severity of patients, and the treatments that influence disease progression. The study will also seek to identify the causes of exacerbations and how this affects the course of the disease. Patients will be contacted via the outpatient clinics of the 8 participating institutions under the auspices of the Spanish Respiratory Diseases Networking System (CIBER). In the inclusion visit, a standardized clinical history will be obtained, a clinical examination, including blood pressure, body mass index, complete respiratory function tests, and FENO will be performed, and the Asthma Control Test (ACT), Morisky-Green test, Asthma Quality of Life Questionnaire (Mini AQLQ), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Hospital Anxiety and Depression scale (HADS) will be administered. A specific electronic database has been designed for data collection. Exhaled breath condensate, urine and blood samples will also be collected. Non-specific bronchial hyperresponsiveness testing with methacholine will be performed and an induced sputum sample will be collected at the beginning of the study and every 24 months. A skin prick test for airborne allergens and a chest CT will be performed at the beginning of the study and repeated every 5 years.
Copyright © 2018 SEPAR. All rights reserved.

Entities:  

Keywords:  Asma eosinofílica; Asma neutrofílica; Biomarcadores; Biomarkers; Bronchiectasis; Bronquiectasias; Eosinophilic asthma; Epigenetics; Epigenética; Exacerbaciones; Exacerbations; Fenotipo; Fixed airflow obstruction; Neutrophilic asthma; Obstrucción fija; Phenotype

Year:  2018        PMID: 29566971     DOI: 10.1016/j.arbres.2017.12.012

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma.

Authors:  José A Cañas; Marcela Valverde-Monge; José M Rodrigo-Muñoz; Beatriz Sastre; Marta Gil-Martínez; Raquel García-Latorre; Manuel J Rial; Aida Gómez-Cardeñosa; Mar Fernández-Nieto; Erwin J Pinillos-Robles; María J Rodríguez-Nieto; Nicolás González-Mangado; Joaquín Sastre; Victoria Del Pozo
Journal:  J Pers Med       Date:  2021-01-28

2.  Risk factors for the development of bronchiectasis in patients with asthma.

Authors:  Donghai Ma; María-Jesús Cruz; Iñigo Ojanguren; Christian Romero-Mesones; Diego Varona-Porres; Xavier Munoz
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

3.  How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?

Authors:  Diana Betancor; José María Olaguibel; José Manuel Rodrigo-Muñoz; Ebymar Arismendi; Pilar Barranco; Blanca Barroso; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Elena Curto; Victoria Del Pozo; Francisco-Javier González-Barcala; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Cesar Picado; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto; Antonio Valero; Marcela Valverde-Monge; Joaquin Sastre
Journal:  Clin Transl Allergy       Date:  2022-08-20       Impact factor: 5.657

4.  Role of miR-185-5p as modulator of periostin synthesis and smooth muscle contraction in asthma.

Authors:  José M Rodrigo-Muñoz; José A Cañas; Beatriz Sastre; Marta Gil-Martínez; Raquel García Latorre; Joaquín Sastre; Victoria Del Pozo
Journal:  J Cell Physiol       Date:  2021-10-26       Impact factor: 6.513

5.  The Genomics and Metagenomics of Asthma Severity (GEMAS) Study: Rationale and Design.

Authors:  Javier Perez-Garcia; José M Hernández-Pérez; Ruperto González-Pérez; Olaia Sardón; Elena Martin-Gonzalez; Antonio Espuela-Ortiz; Elena Mederos-Luis; Ariel Callero; Esther Herrera-Luis; Paula Corcuera; Inmaculada Sánchez-Machín; Paloma Poza-Guedes; Luis Manuel González García; Purificación Ramírez-Martín; Lorenzo Pérez-Negrín; Hemily Izaguirre-Flores; Javier Barrios-Recio; Eva Pérez-Rodríguez; Julia Alcoba-Florez; José A Cañas; José M Rodrigo Muñoz; Victoria Del Pozo; Javier Korta-Murua; Lina I Pérez Méndez; Mariano Hernandez-Ferrer; Jesús Villar; Fabian Lorenzo-Diaz; Maria Pino-Yanes
Journal:  J Pers Med       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.